← Other Open Calls

Alzheimer's Drugs Discovery Foundation

Closing dates:

  • Topic: Aid for carrying out research projects related to Alzheimer's and / or other dementias, carried out by researchers, basic or clinical, linked to universities, university medical centers or biotechnology companies. The following modalities are differentiated:
  • Prevention Beyond The Pipeline 2022: Help for the financing of comparative studies, clinical trials and / or epidemiological studies in which it is investigated whether the use or choice of a drug may alter the risk of suffering from dementia or cognitive impairment.
    • Budget: Up to 3,000,000$
    • Duration: it will depend on the needs of the project.
  • Program To Accelerate Clinical Trials (Pact) 2022: Support for funding clinical trials testing innovative pharmacological interventions for the treatment of Alzheimer's and other related dementias.
    • Budget: Up to 3,000,000€
    • Duration: it will depend on the needs of the project.
  • Drug Development Program 2022: Aid for the financing of a preclinical research project in in vivo models for the development of drugs related to Alzheimer's and other dementias, which have high clinical and commercial applicability.
    • Budget: Up to 600,000$
    • Duration: one year (with the possibility of renewal).
  • Neuroimaging And Csf Biomarker Program 2022: Aid for the financing of projects for the development of biomarkers for which there is a clear clinical need for Alzheimer's disease and related dementias.
    • Budget: Up to 600,000$
    • Duration: one year (with the possibility of renewal).